Nadine Abi-Jaoudeh, Jennifer Brooke Valerin, Dayantha Fernando, Fa-Chyi Lee, April Choi, David Imagawa, Justin Glavis-Bloom, Maha Jarmakani, Kun-Ming Chan, Kuei-An Chen, Ying-Chieh Lai, Chia-Yu Yang, Ian Yi-Feng Chang, Chih-Yuan Chung, Chang-Hsien Liu, Farshid Dayyani. "A phase 2, open-label single-arm, multi-center study of trans-arterial tirapazamine embolization (TATE) combined with nivolumab (nivo) in patients with advanced immunotherapy-refractory hepatocellular carcinoma (HCC).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.2_suppl.538